Frontlight ResearchEarly access
Active, not recruitingNo phase
A Neurofeedback Booster for Emotion Regulation Therapy
Key facts
- Who runs it
- Christian Paret
- Where
- Germany1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 44 people, planned
- Started
- 21 Jul 2020
- Ended
- Dec 2025
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Neurofeedback
- Record updated
- 11 March 2025
Who can take part
- Age
- 18 years to 50 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- DSM-5 BPD diagnosis
- informed consent
- EtOH and tox negative on the day of neurofeedback
- BSL-23 score >=1.87 at DBT halftime
Who cannot take part
- epilepsy
- life-time diagnosis schizophrenia or bipolar disorder I
- significant current or past neurological illness
- pharmacotherapy with opiates
- standing benzodiazepines (bedtime-only benzodiazepines and anti-histamines allowed)
- pregnancy
- BMI<16.5
- usual safety criteria for magnetic resonance imaging
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This is a proof-of-concept study that aims to test the additional value of adjuvant neurofeedback treatment for psychotherapy. Three sessions of real-time fMRI neurofeedback will be administered to N=22 patients with BPD while they receive residential Dialectical Behavior Therapy treatment. In addition, outcomes are assessed from a control group with same sample size who do not receive the treatment.
The 2 groups in the trial
- TreatmentTreatment being tested
Treatment: Neurofeedback
- ControlNo study treatment, for comparison
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- BrainBoost - A Neurofeedback Booster for Emotion Regulation Therapy
- Publications
- Record updated
- 11 March 2025